Comparative Effectiveness of Symbicort vs. Advair Among COPD Patients

Evaluation of Symbicort® Turbuhaler® (Budesonide/Formoterol) in Chronic Obstructive Pulmonary Disease (COPD)

NCT00837629 ·Status: COMPLETED

A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD

NCT00419744 ·Status: COMPLETED ·Phase: PHASE3

Effect of Symbicort ® on GR in Sputum in COPD

NCT01787097 ·Status: COMPLETED ·Phase: PHASE4

Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD)

NCT03197818 ·Status: COMPLETED ·Phase: PHASE3

Comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients With Cronic Obstructive Pulmonary Disease

NCT02157935 ·Status: COMPLETED ·Phase: PHASE3

BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate)

NCT00929851 ·Status: COMPLETED ·Phase: PHASE3

A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and Symbicort® pMDI 2 x 80/4.5 μg Bid With Formoterol Turbuhaler®, Budesonide pMDI, the Combination of Formoterol Turbuhaler® and Budesonide pMDI, and Placebo in COPD Patients

NCT00206154 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Formoterol/Fluticasone and Salmeterol/Fluticasone in Patients With Moderate-to-severe COPD

NCT01393145 ·Status: WITHDRAWN ·Phase: PHASE3

A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50

NCT03562923 ·Status: UNKNOWN ·Phase: PHASE3

Phase IV O2 Consumption Study in COPD Patients.

NCT02533505 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01415518 ·Status: COMPLETED ·Phase: PHASE4

The Effect of Fluticasone/Salmeterol Combination on Exertional Breathlessness in Patients With Mild COPD

NCT00559312 ·Status: COMPLETED ·Phase: NA

Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo

NCT01760304 ·Status: TERMINATED ·Phase: PHASE4

Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Symbicort® Compared to Seretide®

NCT00542880 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Efficacy on Exercise Tolerance of Symbicort (Budesonide/Formoterol) Compared to Placebo and Oxis in Patients With Severe COPD

NCT00489853 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD

NCT00476099 ·Status: COMPLETED ·Phase: PHASE3

Foster® pMDI (CHF 1535) Versus Symbicort® Turbohaler in COPD Patient (FORSYYN)

NCT03888131 ·Status: COMPLETED ·Phase: PHASE3

Comparison Between Symbicort® and Prednisolone in COPD

NCT00259779 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD

NCT04320342 ·Status: COMPLETED ·Phase: PHASE3

SYMBICORT® in the Treatment of COPD

NCT00564499 ·Status: COMPLETED

Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01381471 ·Status: COMPLETED

Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations

NCT00115492 ·Status: COMPLETED ·Phase: PHASE4

Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment

NCT01395875 ·Status: COMPLETED

Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD

NCT00421122 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01069289 ·Status: COMPLETED ·Phase: PHASE3